BACKGROUND: Cervical cancer is a major public health problem in resource-limited settings, particularly among HIV-infected women. Given the challenges of cytology-based approaches, the efficiency of new screening programs need to be assessed. SETTING: Community and hospital-based clinics in Gaborone, Botswana. OBJECTIVE: To determine the feasibility and efficiency of the "see and treat" approach using visual inspection acetic acid (VIA) and enhanced digital imaging (EDI) for cervical cancer prevention in HIV-infected women. METHODS: A 2-tier community-based cervical cancer prevention program was implemented. HIV-infected women were screened by nurses at the community using the VIA/EDI approach. Low-grade lesions were treated with cryotherapy on the same visit. Women with complex lesions were referred to our second tier specialized clinic for evaluation. Weekly quality control assessments were performed by a specialist in collaboration with the nurses on all pictures taken. RESULTS: From March 2009 through January 2011, 2175 patients were screened for cervical cancer at our community-based clinic. Two hundred fifty-three patients (11.6%) were found to have low-grade lesions and received same-day cryotherapy. One thousand three hundred forty-seven (61.9%) women were considered to have a normal examination, and 575 (27.3%) were referred for further evaluation and treatment. Of the 1347 women initially considered to have normal exams, 267 (19.8%) were recalled based on weekly quality control assessments. Two hundred ten (78.6%) of the 267 recalled women, and 499 (86.8%) of the 575 referred women were seen at the referral clinic. Of these 709 women, 506 (71.4%) required additional treatment. Overall, 264 cervical intraepithelial neoplasia stage 2 or 3 were identified and treated, and 6 microinvasive cancers identified were referred for further management. CONCLUSIONS: Our "see and treat" cervical cancer prevention program using the VIA/EDI approach is a feasible, high-output and high-efficiency program, worthy of considering as an additional cervical cancer screening method in Botswana, especially for women with limited access to the current cytology-based screening services.
BACKGROUND:Cervical cancer is a major public health problem in resource-limited settings, particularly among HIV-infectedwomen. Given the challenges of cytology-based approaches, the efficiency of new screening programs need to be assessed. SETTING: Community and hospital-based clinics in Gaborone, Botswana. OBJECTIVE: To determine the feasibility and efficiency of the "see and treat" approach using visual inspection acetic acid (VIA) and enhanced digital imaging (EDI) for cervical cancer prevention in HIV-infectedwomen. METHODS: A 2-tier community-based cervical cancer prevention program was implemented. HIV-infectedwomen were screened by nurses at the community using the VIA/EDI approach. Low-grade lesions were treated with cryotherapy on the same visit. Women with complex lesions were referred to our second tier specialized clinic for evaluation. Weekly quality control assessments were performed by a specialist in collaboration with the nurses on all pictures taken. RESULTS: From March 2009 through January 2011, 2175 patients were screened for cervical cancer at our community-based clinic. Two hundred fifty-three patients (11.6%) were found to have low-grade lesions and received same-day cryotherapy. One thousand three hundred forty-seven (61.9%) women were considered to have a normal examination, and 575 (27.3%) were referred for further evaluation and treatment. Of the 1347 women initially considered to have normal exams, 267 (19.8%) were recalled based on weekly quality control assessments. Two hundred ten (78.6%) of the 267 recalled women, and 499 (86.8%) of the 575 referred women were seen at the referral clinic. Of these 709 women, 506 (71.4%) required additional treatment. Overall, 264 cervical intraepithelial neoplasia stage 2 or 3 were identified and treated, and 6 microinvasive cancers identified were referred for further management. CONCLUSIONS: Our "see and treat" cervical cancer prevention program using the VIA/EDI approach is a feasible, high-output and high-efficiency program, worthy of considering as an additional cervical cancer screening method in Botswana, especially for women with limited access to the current cytology-based screening services.
Authors: Johannes Berkhof; Martine C de Bruijne; Gilda D Zielinski; Nicole W J Bulkmans; Lawrence Rozendaal; Peter J F Snijders; René H M Verheijen; Chris J L M Meijer Journal: Int J Cancer Date: 2006-04-01 Impact factor: 7.396
Authors: Howard D Strickler; Robert D Burk; Melissa Fazzari; Kathryn Anastos; Howard Minkoff; L Stewart Massad; Charles Hall; Melanie Bacon; Alexandra M Levine; D Heather Watts; Michael J Silverberg; Xiaonan Xue; Nicolas F Schlecht; Sandra Melnick; Joel M Palefsky Journal: J Natl Cancer Inst Date: 2005-04-20 Impact factor: 13.506
Authors: B M Nene; S Deshpande; K Jayant; A M Budukh; P S Dale; D A Deshpande; A S Chiwate; S G Malvi; S Deokar; D M Parkin; R Sankaranarayanan Journal: Int J Cancer Date: 1996-12-11 Impact factor: 7.396
Authors: Elisabeth D Riviello; Timothy R Sterling; Bryan Shepherd; Tsetsele Fantan; Joseph Makhema Journal: AIDS Res Hum Retroviruses Date: 2007-12 Impact factor: 2.205
Authors: R Sankaranarayanan; B M Nene; K Dinshaw; R Rajkumar; S Shastri; R Wesley; P Basu; R Sharma; S Thara; A Budukh; D M Parkin Journal: Salud Publica Mex Date: 2003
Authors: Hyungsoon Im; Cesar M Castro; Huilin Shao; Monty Liong; Jun Song; Divya Pathania; Lioubov Fexon; Changwook Min; Maria Avila-Wallace; Omar Zurkiya; Junsung Rho; Brady Magaoay; Rosemary H Tambouret; Misha Pivovarov; Ralph Weissleder; Hakho Lee Journal: Proc Natl Acad Sci U S A Date: 2015-04-13 Impact factor: 11.205
Authors: Jason A Efstathiou; Memory Bvochora-Nsingo; David P Gierga; Mukendi K Alphonse Kayembe; Mompati Mmalane; Anthony H Russell; Jonathan J Paly; Carolyn Brown; Zola Musimar; Jeremy S Abramson; Kathy A Bruce; Talkmore Karumekayi; Rebecca Clayman; Ryan Hodgeman; Joseph Kasese; Remigio Makufa; Elizabeth Bigger; Gita Suneja; Paul M Busse; Thomas C Randall; Bruce A Chabner; Scott Dryden-Peterson Journal: Int J Radiat Oncol Biol Phys Date: 2014-07-01 Impact factor: 7.038
Authors: Sudha Sivaram; Michael A Sanchez; Barbara K Rimer; Jonathan M Samet; Russell E Glasgow Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-09-01 Impact factor: 4.254